Date published: 2026-6-27

1-800-457-3801

SCBT Portrait Logo
Seach Input

Decatromicin B (CAS 235097-64-0)

0.0(0)
Write a reviewAsk a question

Application:
Decatromicin B is a potent antibiotic with activity against sensitive and resistant straints
CAS Number:
235097-64-0
Molecular Weight:
855.84
Molecular Formula:
C45H56Cl2N2O10
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

Decatromicin B, with the CAS number 235097-64-0, is a lesser-known antibiotic compound belonging to the class of polyketides known for their complex molecular structures and diverse biological activities. This chemical is characterized by a macrolide framework which is pivotal in its mechanism of action, primarily targeting bacterial RNA polymerase. By binding to this essential enzyme, Decatromicin B disrupts the transcription process, which is critical for bacterial gene expression. This interaction inhibits the synthesis of mRNA, thereby preventing the production of proteins necessary for bacterial survival and proliferation. The ability of Decatromicin B to bind and inhibit RNA polymerase makes it a valuable tool in microbiological research, especially in studies focused on understanding the nuances of bacterial transcription mechanisms and the development of resistance to transcription inhibitors. In the research setting, Decatromicin B is utilized to explore the structural and functional dynamics of RNA polymerase, to map the antibiotic binding sites, and to understand how modifications in these sites influence the efficacy of transcription inhibitors. These studies are crucial for advancing knowledge in microbial physiology and for the design of novel antibiotics that can circumvent resistance mechanisms, thereby contributing to the field of bacterial pathogenesis and antibiotic discovery.


Decatromicin B (CAS 235097-64-0) References

  1. Decatromicins A and B, new antibiotics produced by Actinomadura sp. MK73-NF4. I. Taxonomy, isolation, physico-chemical properties and biological activities.  |  Momose, I., et al. 1999. J Antibiot (Tokyo). 52: 781-6. PMID: 10726925
  2. Decatromicins A and B, new antibiotics produced by Actinomadura sp. MK73-NF4. II. Structure determination.  |  Momose, I., et al. 1999. J Antibiot (Tokyo). 52: 787-96. PMID: 10726926
  3. Recent advances in the field of bioactive tetronates.  |  Vieweg, L., et al. 2014. Nat Prod Rep. 31: 1554-84. PMID: 24965099
  4. Tetrodecamycin: An unusual and interesting tetronate antibiotic.  |  Gverzdys, T., et al. 2016. Bioorg Med Chem. 24: 6269-6275. PMID: 27246856
  5. Marine Mammal Microbiota Yields Novel Antibiotic with Potent Activity Against Clostridium difficile.  |  Ochoa, JL., et al. 2018. ACS Infect Dis. 4: 59-67. PMID: 29043783
  6. Secondary Metabolites of Actinomycetales as Potent Quorum Sensing Inhibitors Targeting Gram-Positive Pathogens: In Vitro and In Silico Study.  |  Desouky, SE., et al. 2022. Metabolites. 12: PMID: 35323689
  7. Antibacterial Spirotetronate Polyketides from an Actinomadura sp. Strain A30804.  |  Ching, KC., et al. 2022. Molecules. 27: PMID: 36500287
  8. Chemistry and biology of specialized metabolites produced by Actinomadura.  |  Dashti, Y. and Errington, J. 2024. Nat Prod Rep. 41: 370-401. PMID: 38099919
  9. [Staging of Hodgkin's disease by laparotomy: therapeutic consequences].  |  Siewert, R., et al. 1979. Chirurg. 50: 478-83. PMID: 391512

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

Decatromicin B, 0.5 mg

sc-391512
0.5 mg
$315.00